Review
Aug 2026
Bioactive nanomedicines for multidrug-resistant colorectal cancer: Actionable mechanisms, emerging particle classes, and translational barriers.
This review critically examines when nanomedicine can make such mechanistic activity pharmacologically and translationally meaningful in CRC and compares major nanomedicine design strategies, and assess nano-bio interactions, repeat-dose safety, manufacturing and clinical positioning.
Milad Rasouli, Fatemeh Babaei, Nadia Fallahhossein et al.
· Advanced Drug Delivery Revie... · 0 citations